p.Leu636Pro mutation is associated with cystic fibrosis transmembrane conductance regulator‐related disorders (congenital bilateral absence of vas deferens)

Publisher： John Wiley & Sons Inc

E-ISSN： 1442-2042|22|8|803-804

ISSN： 0919-8172

Source： INTERNATIONAL JOURNAL OF UROLOGY, Vol.22, Iss.8, 2015-08, pp. : 803-804

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial Comment to p.Leu636Pro mutation is associated with cystic fibrosis transmembrane conductance regulator‐related disorders (congenital bilateral absence of vas deferens)

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 8, 2015-08 ,pp. : 804-804

John Wiley & Sons Inc

Access to resources Recommend Favorite

Congenital bilateral absence of the vas deferens as an atypical form of cystic fibrosis: reproductive implications and genetic counseling

By  

ANDROLOGY, Vol. 6, Iss. 1, 2018-01 ,pp. : 127-135

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeted Therapy for Cystic Fibrosis: Cystic Fibrosis Transmembrane Conductance Regulator Mutation-Specific Pharmacologic Strategies

By Rubenstein Ronald C.  

Molecular Diagnosis & Therapy, Vol. 10, Iss. 5, 2006-01 ,pp. : 293-301

Adis International

Access to resources Recommend Favorite

Cystic Fibrosis Transmembrane Conductance Regulator Recruitment to Phagosomes in Neutrophils

By  

Journal of Innate Immunity, Vol. 5, Iss. 3, 2013-03 ,pp. : 219-230

Karger

Access to resources Recommend Favorite

CLINICAL, ANDROLOGICAL AND GENETIC CHARACTERISTICS OF PATIENTS WITH CONGENITAL BILATERAL ABSENCE OF VAS DEFERENS (CBAVD)

By Samli H.  

Archives of Andrology, Vol. 52, Iss. 6, 2006-11 ,pp. : 471-477

Informa Healthcare

Access to resources Recommend Favorite